Ferroptosis-centered Disease Response Information
General Information of the Disease (ID: DIS00023)
| Name |
Hypopharyngeal cancer
|
||||
|---|---|---|---|---|---|
| ICD |
ICD-11: 2B6D
|
||||
Full List of Target(s) of This Ferroptosis-centered Disease
Unspecific Target
| In total 1 item(s) under this target | ||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target | [1] | |||
| Responsed Disease | Hypopharyngeal carcinoma [ICD-11: 2B6D] | |||
| Responsed Drug | Punicic Acid | Investigative | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | |||
| In Vitro Model | FaDu cells | Hypopharyngeal squamous cell carcinoma | Homo sapiens | CVCL_1218 |
| HCT 116 cells | Colon carcinoma | Homo sapiens | CVCL_0291 | |
| Response regulation | Punicic acid is highly cytotoxic to HCT-116 colorectal and FaDu hypopharyngeal carcinoma cells grown either in monolayers or as three-dimensional spheroids. It induces significant lipid peroxidation and its effects are prevented by the addition of ferroptosis inhibitors. | |||
